Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Q3 2025 value amounting to 0.35%.

  • Enanta Pharmaceuticals' Return on Capital Employed rose 200.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.3% for FY2025, which is 300.0% up from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.35% for Q3 2025, which was up 200.0% from 0.36% recorded in Q2 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Return on Capital Employed registered a high of 0.19% during Q1 2021, and its lowest value of 0.42% during Q1 2023.
  • For the 5-year period, Enanta Pharmaceuticals' Return on Capital Employed averaged around 0.34%, with its median value being 0.35% (2025).
  • Per our database at Business Quant, Enanta Pharmaceuticals' Return on Capital Employed tumbled by -2100bps in 2021 and then skyrocketed by 500bps in 2024.
  • Enanta Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.32% in 2021, then fell by -15bps to 0.36% in 2022, then dropped by -2bps to 0.37% in 2023, then rose by 5bps to 0.35% in 2024, then dropped by 0bps to 0.35% in 2025.
  • Its Return on Capital Employed was 0.35% in Q3 2025, compared to 0.36% in Q2 2025 and 0.35% in Q1 2025.